Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results

Synthetic Biologics (SYN) Misses Q3 EPS by 8c

November 4, 2019 4:27 PM EST

Synthetic Biologics (NYSE: SYN) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).

"During the third quarter, we remained sharply focused on the advancement of our portfolio of GI-focused clinical programs which leverage the microbiome to improve the health of patients," stated Steven A. Shallcross, Chief Executive and Financial Officer. "We were pleased to announce our clinical trial collaboration with Washington University School of Medicine in... More